Caldwell Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$95.7K Sell
2,193
-1,559
-42% -$72.2K 0.01% 417
2026
Q2
$160K Sell
3,752
-6,188
-62% -$336K 0.01% 355
2026
Q1
$624K Buy
9,940
+3,101
+45% +$248K 0.06% 205
2025
Q4
$652K Buy
6,839
+1,759
+35% +$172K 0.06% 204
2025
Q3
$496K Buy
5,080
+160
+3% +$16.6K 0.05% 228
2025
Q2
$528K Buy
4,920
+1,325
+37% +$134K 0.05% 217
2025
Q1
$363K Buy
3,595
+802
+29% +$80.8K 0.04% 246
2024
Q4
$249K Buy
2,793
+173
+7% +$15.2K 0.03% 292
2024
Q3
$220K Buy
2,620
+771
+42% +$60.8K 0.02% 305
2024
Q2
$142K Buy
1,849
+61
+3% +$4.46K 0.02% 343
2024
Q1
$122K Buy
1,788
+537
+43% +$34.5K 0.01% 365
2023
Q4
$72.3K Buy
1,251
+1,045
+507% +$55.8K 0.01% 403
2023
Q3
$10.9K Buy
+206
New +$10.8K ﹤0.01% 608
2022
Q1
– Sell
-61
Closed -$2.59K – 749
2021
Q4
$2.59K Buy
+61
New +$2.56K ﹤0.01% 705

Other funds holding BSX

Caldwell Trust's BSX Position: Q3 2026 in Review

Caldwell Trust reduced its Boston Scientific (BSX) stake by 42% in Q3 2026, selling an estimated $72.2K and leaving 2,193 shares worth $95.7K. The position accounts for 0.01% of the portfolio, ranked #417.

Caldwell Trust first reported a position in BSX in Q4 2021 and has held it in 14 quarters since. The position peaked at $652K in Q4 2025. 563 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Caldwell Trust held 2,193 shares of Boston Scientific worth $95.7K as of Q3 2026.
  • Caldwell Trust sold 1,559 Boston Scientific shares in Q3 2026, an estimated $72.2K.
  • Boston Scientific made up 0.01% of Caldwell Trust's portfolio in Q3 2026, its #417 holding.
  • Caldwell Trust first reported a position in Boston Scientific in Q4 2021 and has held it in 14 quarters since.
  • Caldwell Trust's Boston Scientific position peaked at $652K in Q4 2025.
  • 563 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.